BRAFV600E-Associated Gene Expression Profile: Early Changes in the Transcriptome, Based on a Transgenic Mouse Model of Papillary Thyroid Carcinoma-Reference-Cited by-同舟云学术

BRAFV600E-Associated Gene Expression Profile: Early Changes in the Transcriptome, Based on a Transgenic Mouse Model of Papillary Thyroid Carcinoma

Published:2015-12-01 Issue:12 Volume:10 Page:e0143688
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Rusinek Dagmara,Swierniak Michal,Chmielik Ewa,Kowal Monika,Kowalska Malgorzata,Cyplinska Renata,Czarniecka Agnieszka,Piglowski Wojciech,Korfanty Joanna,Chekan Mykola,Krajewska Jolanta,Szpak-Ulczok Sylwia,Jarzab Michal,Widlak Wieslawa,Jarzab Barbara

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference55 articles.

1. Mutations of the BRAF gene in human cancer;H Davies;Nature,2002

2. BRAF mutation in papillary thyroid carcinoma;Y Cohen;J Natl Cancer Inst,2003

3. Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer;M Xing;J Clin Endocrinol Metab,2004

4. BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC;P Soares;Oncogene,2003

5. Investigation of V600E BRAF mutation in papillary thyroid carcinoma in the Polish population;E Brzezianska;Neuro Endocrinol Lett,2007

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene Expression Profiles of AHNAK2, DCSTAMP, FN1, and TERT Correlate With Mutational Status and Recurrence in Papillary Thyroid Carcinoma;Genes, Chromosomes and Cancer;2024-08

2. Could Oxidative Stress Play a Role in the Development and Clinical Management of Differentiated Thyroid Cancer?;Cancers;2023-06-14

3. Anchoring Filament Protein Ladinin-1 is an Immunosuppressive Microenvironment and Cold Tumor Correlated Prognosticator in Lung Adenocarcinoma;Biochemical Genetics;2023-04-01

4. Papillary Thyroid Carcinoma: A Narrative Review on the Most Important Genetic and Epigenetic Alterations;Current Pharmacogenomics and Personalized Medicine;2023-04

5. Unveiling a BRAF Signature Proficient in Accurately Capturing Oncogenic Activity and Guiding Prognostic Prediction Across Multiple Cancers;2023